Elimination of Oral Corticosteroids (OCS) with Benralizumab Treatment in OCS-Dependent Asthmatics Using a Rapid, Personalized Algorithm: The PONENTE Trial

Andrew Menzies-Gow, Mark Gurnell, Liam Heaney, Jonathan Corren, Elisabeth Bel, Jorge Maspero, Timothy Harrison, David Jackson, David Price, Njira Lugogo, James Kreindler, Annie Burden, Alex de Giorgio Miller, Ubaldo Martin, Kelly Padilla, Esther Garcia Gil

Research output: Contribution to journalAbstractpeer-review

Abstract

Programs and Abstracts of Papers to be Presented During Virtual Scientific Sessions: 2021 AAAAI Virtual Annual Meeting
Original languageEnglish
Article numberAB249
Number of pages1
JournalJournal of Allergy and Clinical Immunology
Volume147
Issue number2, Supplement
Early online date1 Feb 2021
DOIs
Publication statusPublished - Feb 2021
Event2021 AAAAI VIRTUAL ANNUAL MEETING
- Virtual
Duration: 26 Feb 20211 May 2021
https://annualmeeting.aaaai.org/

Fingerprint Dive into the research topics of 'Elimination of Oral Corticosteroids (OCS) with Benralizumab Treatment in OCS-Dependent Asthmatics Using a Rapid, Personalized Algorithm: The PONENTE Trial'. Together they form a unique fingerprint.

Cite this